Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | 108,176 | reported | 30 Jun 2025 | tx 5+486,361 |
| RayzeBio, Inc. | 0 | reported | 26 Feb 2024 | tx 5+164,000−693,955 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jun 2025 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 108,176 | 0.00 USD | deriv |
| 14 Feb 2025 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 116,585 | 0.00 USD | deriv |
| 14 Feb 2025 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 56,600 | 0.00 USD | deriv |
| 21 Oct 2024 | PURCHASE | Inhibikase Therapeutics, Inc. | 145,000 | 1.37 USD | |
| 21 Oct 2024 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 78,433 | 62.50 USD | |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 149,777 | — | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 164,000 | — | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 301,745 | — | deriv |
| 17 Nov 2023 | GRANT_AWARD | RayzeBio, Inc. | 164,000 | 0.00 USD | deriv |